The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 28 May 2002 doi:10.1084/jem.20020207
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 151K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, T.
Right arrow Articles by Fukuhara, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, T.
Right arrow Articles by Fukuhara, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2002/6/1507/ $5.00
The Journal of Experimental Medicine, Volume 195, Number 11, June 3, 2002 1507-1512


Brief Definitive Report

Interferon-{alpha} and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets

Tomoki Ito1, Ryuichi Amakawa1, Tsuneyasu Kaisho2,4, Hiroaki Hemmi2,3, Kenichirou Tajima1, Kazutaka Uehira1, Yoshio Ozaki1, Hideyuki Tomizawa5, Shizuo Akira2,3 and Shirou Fukuhara1

1 First Department of Internal Medicine, Kansai Medical University, Osaka 570-8506, Japan
2 Department of Host Defense, Research Institute for Microbial Diseases, Osaka University
3 Solution-oriented Research for Science and Technology, Japan Science and Technology Corporation, Osaka 565-0871, Japan
4 RIKEN Research Center for Allergy and Immunology, Kanagawa 230-0045, Japan
5 Pharmaceuticals and Biotechnology Laboratory, Japan Energy Corporation, Saitama 335-8502, Japan

Address correspondence to Ryuichi Amakawa, First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570-8506, Japan. Phone: 81-6-6993-9453; Fax: 81-6-6994-8344; E-mail: amakawa{at}takii.kmu.ac.jp

Dendritic cells (DCs) play a crucial role in the immune responses against infections by sensing microbial invasion through toll-like receptors (TLRs). In humans, two distinct DC subsets, CD11c- plasmacytoid DCs (PDCs) and CD11c+ myeloid DCs (MDCs), have been identified and can respond to different TLR ligands, depending on the differential expression of cognate TLRs. In this study, we have examined the effect of TLR-7 ligands on human DC subsets. Both subsets expressed TLR-7 and could respond to TLR-7 ligands, which enhanced the survival of the subsets and upregulated the surface expression of costimulatory molecules such as CD40, CD80, and CD86. However, the cytokine induction pattern was distinct in that PDCs and MDCs produced interferon (IFN)-{alpha} and interleukin (IL)-12, respectively. In response to TLR-7 ligands, the Th1 cell supporting ability of both DC subsets was enhanced, depending on the cytokines the respective subsets produced. This study demonstrates that TLR-7 exerts its biological effect in a DC subset-specific manner.

Key Words: immunity • cytokines • imidazoquinolines • pathogen-associated molecular patterns • Th cell responses


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS